
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1009119-64-5 |
| Catalog No. | 2A-9091555 |
| Chinese Name | 达卡他韦 |
| Synonyms | Daclatasvir; EBP 883; BMS-790052; BMS790052 |
| Molecular Formula | C40H50N8O6 |
| Molecular Weight | 738.89 |
| Purity | 98 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 1071.2±65.0 °C at 760 mmHg |
| Appearance | White to off-white or light yellow powder |
| Storage Condition | Room temperature, dry, sealed |
| Application | Daclatasvir is a potent inhibitor of HCV NS5A against genotype 1a and 1b replicons with average EC50 of 50 and 9 pM. |
| PubChem ID | 57269885 |
| MDL Number | C40H50N8O6 |
| SMILES | COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C |
| InChI | InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1 |
| InChI Key | FKRSSPOQAMALKA-CUPIEXAXSA-N |
| MSDS | msds/91555_1_1009119_64_5.pdf |
| Transport Info | Product Name: Daclatasvir (BMS-790052) |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| VALPROIC ACID-D6 | 87745-18-4 | 2A-9091533 |
| N-desmethyl sildenafil-d8 | 2A-173224 | 2A-9091534 |
| GABAPENTIN-D4 | 1185039-20-6 | 2A-9091535 |
| (R)-(-)-IBUPROFEN | 51146-57-7 | 2A-9091544 |
| 4-DesMethyl-3-Methyl Celecoxib | 170570-01-1 | 2A-9091546 |
| Ledipasvir | 1256388-51-8 | 2A-9091557 |
| 5-HYDROXY ESOMEPRAZOLE | 196489-27-7 | 2A-9091568 |
| 9-Piperazino Levofloxacin | 178912-62-4 | 2A-9091569 |
| 4-Epiminocycline | 43168-51-0 | 2A-9091576 |
| SERTRALINE HCL | 79645-15-1 | 2A-9091637 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA